SCHEMBL21865645

SCHEMBL21865645

O=c1cc(-c2ccc(OCCO)c(F)c2)oc2c(Cl)cccc12

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 9/20 0.46
▸ CYP1A1 P04798 7/20 0.46
▸ CYP1A2 P05177 7/20 0.46
▸ ABCC1 P33527 2/20 0.43
▸ ABCG2 Q9UNQ0 2/20 0.43
▸ PRKAB2 O43741 2/20 0.43
▸ PRKAG1 P54619 2/20 0.43
▸ PRKAA2 P54646 2/20 0.43
▸ PRKAA1 Q13131 2/20 0.43
▸ PRKAG3 Q9UGI9 2/20 0.43
▸ PRKAG2 Q9UGJ0 2/20 0.43
▸ PRKAB1 Q9Y478 2/20 0.43
▸ CSNK2A2 P19784 2/20 0.42
▸ CSNK2B P67870 2/20 0.42
▸ CSNK2A1 P68400 2/20 0.42
▸ ABCB1 P08183 1/20 0.41
▸ PRKDC P78527 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.40
▸ XDH P47989 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21865746 0.90 CSNK2A2 (0.44) CYP1B1CYP1A1CYP1A2ABCC1ABCG2
SCHEMBL21886510 0.89 ABCC1 (0.47) CYP1B1CYP1A1CYP1A2ABCC1ABCG2
SCHEMBL30744120 0.84 ABCC1 (0.57) CYP1B1CYP1A1CYP1A2ABCC1ABCG2
SCHEMBL21801140 0.84 ABCC1 (0.57) CYP1B1CYP1A1CYP1A2ABCC1ABCG2
SCHEMBL21801217 0.83 SIGMAR1 (0.39) CYP1B1CYP1A1CYP1A2ABCC1ABCG2
SCHEMBL21801254 0.83 SIGMAR1 (0.39) CYP1B1CYP1A1CYP1A2ABCC1ABCG2
SCHEMBL21801153 0.83 ABCB1 (0.53) CYP1B1CYP1A1CYP1A2ABCC1ABCG2
SCHEMBL21801111 0.80 CYP1B1 (0.54) CYP1B1CYP1A1CYP1A2CSNK2A2CSNK2B
SCHEMBL30744127 0.80 CYP1B1 (0.54) CYP1B1CYP1A1CYP1A2CSNK2A2CSNK2B
SCHEMBL21801308 0.80 ABCB1 (0.52) CYP1B1CYP1A1CYP1A2ABCC1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020053249-A1 FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-03-19 — — WO disclosed
Send feedback